DEC 02, 2019 8:32 AM PST

New Ultrasound Treatment for Parkinson's Tremors

WRITTEN BY: Annie Lennon

A non-invasive ultrasound procedure may provide lasting relief from tremors in people with Parkinson’s disease (PD) and essential tremor (ET), according to a small study from Italy. 

Tremors are rhythmic, involuntary muscle movements that lead to shaking in the body, typically in the hands. Characteristic of motor system disorders including PD and ET, conventional treatment options for this symptom include exercise and various medications. Should these fail, deep brain stimulation is usually recommended. A surgical procedure in which a small electrode is implanted in the brain connected to a pulse generator implanted in the chest, it is highly invasive and costly. 

Now, however, another option is available for handling these tremors which, according to new research, may be just as effective, if not more so. Known as magnetic resonance-guided focused ultrasound thalamotomy (MRgFUS), the treatment works by focusing beams of sound energy on the thalamus to heat, and eventually destroy a small part of its structure. In doing so, the procedure relieves the opposite side of the body, meaning that treatment to the left side of the brain relieves tremors on the right side of the body and vice versa. 

An incisionless and minimally-invasive approach, the treatment has may advantages over deep brain stimulation, such as a reduced risk of complications from bleeding and infections. Additionally, the approach has shown to have immediate effects and requires less aftercare, unlike deep brain stimulation which requires a break-in period for the electro stimulation as well as longer postoperative hospitalization. 

For the study, Dr. Federco Bruno, a radiologist in the Department of Biotechnical and Applied Clinical Sciences at the University of L’Aquila, Italy, and his team involved 39 patients, at an average of 64.5 year old old. Within the group, 18 had ET, and 21 had PD, each experiencing symptoms for over 10 years. 

After receiving the treatment, 37 out of the 39 patients (or 95%) saw immediate and substantial reductions in their tremors. These results were then sustained in follow-up evaluations, with quality of life evaluations showing significant improvements in both those with PD and ET. 

Although MRgFUS thalamotomy is only available at few sites worldwide, Dr Bruno says that this may change as research on its efficacy as a treatment become more widespread. In the meantime, future research on this treatment will look into treating both sides of the thalamus, as well as seeing how it be applied to other neurological conditions such as epilepsy, neuropathic pain and brain tumors. 


 

Sources: WebMD, EurekAlert and Medical News Today 

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUL 19, 2020
Cannabis Sciences
Cannabis May Relieve Pain from Sickle Cell Disease
JUL 19, 2020
Cannabis May Relieve Pain from Sickle Cell Disease
Due to the rise in opioid-associated deaths, physicians and researchers are on the constant lookout for new, healthier o ...
JUL 19, 2020
Neuroscience
Eating Fish May Protect Brain from Air Pollution
JUL 19, 2020
Eating Fish May Protect Brain from Air Pollution
Researchers have found that a diet high in omega-3 fatty acids may prevent neurodegeneration among older women living in ...
AUG 22, 2020
Drug Discovery & Development
Honey More Effective than Medication to Treat Cough
AUG 22, 2020
Honey More Effective than Medication to Treat Cough
Upper respiratory tract infections are the most common reason for doctors to prescribe antibiotics. However, as most of ...
AUG 25, 2020
Drug Discovery & Development
Drug Combination Reduces Cardiovascular Complications
AUG 25, 2020
Drug Combination Reduces Cardiovascular Complications
According to a new study, combining the drugs hydroxychloroquine (HCQ) and azithromycin (AZM) was shown to reduce cardio ...
AUG 29, 2020
Drug Discovery & Development
MDMA and LSD Combo to Enter Clinical Trials
AUG 29, 2020
MDMA and LSD Combo to Enter Clinical Trials
Scientists from the pharmaceutical company, MindMed, have announced the beginning of Phase 1 clinical trials to test Sch ...
SEP 11, 2020
Drug Discovery & Development
Single Injection Sends Type 2 Diabetes into Remission
SEP 11, 2020
Single Injection Sends Type 2 Diabetes into Remission
Type 2 diabetes affects around 10% of people in the US. Although there is no cure for it, there are some well-known meth ...
Loading Comments...